Robert Balk to Treatment Outcome
This is a "connection" page, showing publications Robert Balk has written about Treatment Outcome.
Connection Strength
0.223
-
Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study. PLoS One. 2018; 13(10):e0205924.
Score: 0.084
-
Roger C. Bone, MD and the evolving paradigms of sepsis. Contrib Microbiol. 2011; 17:1-11.
Score: 0.051
-
Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Dis Mon. 2004 Apr; 50(4):168-213.
Score: 0.031
-
Relationship Between Body Mass Index and Outcomes Among Hospitalized Patients With Community-Acquired Pneumonia. J Infect Dis. 2017 06 15; 215(12):1873-1882.
Score: 0.019
-
Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care. 2011; 15(2):R88.
Score: 0.012
-
Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after study. Clin Ther. 2010 Jul; 32(7):1285-93.
Score: 0.012
-
Radiographic patterns of pulmonary disease. Dis Mon. 1997 Jan; 43(1):1-62.
Score: 0.005
-
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med. 1996 Jun 27; 334(26):1697-702.
Score: 0.004
-
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med. 1995 Jun; 23(6):994-1006.
Score: 0.004